comparemela.com

Latest Breaking News On - Hannah mamuszka - Page 1 : comparemela.com

Breast Cancer Risk: Testing To Tailored Screening, Treatment, and Prevention.

Breast Cancer Risk: Testing To Tailored Screening, Treatment, and Prevention.
ricochet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ricochet.com Daily Mail and Mail on Sunday newspapers.

Hannah-mamuszka
Joe-selvaggi
Ricochet-audio-network-superfeed
Hub-wonk
Apple-podcasts

Hannah Mamuszka – Ricochet

Hannah Mamuszka – Ricochet
ricochet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ricochet.com Daily Mail and Mail on Sunday newspapers.

Hannah-mamuszka
Joe-selvaggi

BTIG Research Raises Bionano Genomics (NASDAQ:BNGO) Price Target to $10.00

Bionano Genomics (NASDAQ:BNGO – Free Report) had its price target hoisted by BTIG Research to $10.00 in a report released on Thursday morning, Marketbeat.com reports. BTIG Research currently has a buy rating on the stock. Separately, LADENBURG THALM/SH SH cut their price objective on Bionano Genomics from $60.00 to $48.00 in a report on Wednesday, […]

Hannah-mamuszka
Securities-exchange-commission
Renaissance-technologies
Bionano-genomics-inc
Kokusai-asset-management-co
Vanguard-group-inc
Mitsubishi-ufj
Bionano-genomics
Free-report
Director-hannah-mamuszka
Exchange-commission
Asset-management

Bionano Genomics, Inc. (NASDAQ:BNGO) Sees Large Decrease in Short Interest

Bionano Genomics, Inc. (NASDAQ:BNGO – Get Free Report) saw a significant drop in short interest in June. As of June 30th, there was short interest totalling 48,120,000 shares, a drop of 19.5% from the June 15th total of 59,800,000 shares. Based on an average trading volume of 10,440,000 shares, the short-interest ratio is currently 4.6 […]

Hannah-mamuszka
Christopherp-stewart
Financial-group
Bionano-genomics-company-profile
Brinker-capital-investments
Verition-fund-management
Lazard-asset-management
Securities-exchange-commission
Nasdaq
Bionano-genomics-inc
Sorce-advisory
Bionano-genomics

Insider Buying: Bionano Genomics, Inc. (NASDAQ:BNGO) Director Buys 65,789 Shares of Stock

Bionano Genomics, Inc. (NASDAQ:BNGO – Get Rating) Director Hannah Mamuszka bought 65,789 shares of the stock in a transaction on Tuesday, June 13th. The shares were acquired at an average cost of $0.76 per share, for a total transaction of $49,999.64. Following the purchase, the director now owns 65,789 shares in the company, valued at […]

Hannah-mamuszka
Arete-wealth-advisors
Nasdaq
Jpmorgan-chase-co
Geode-capital-management
Bionano-genomics-inc
Bionano-genomics-company-profile
Bionano-genomics
Get-rating
Director-hannah-mamuszka
Genomics-trading-down
State-equity-partners

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.